254 related articles for article (PubMed ID: 19308943)
1. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.
Tyagi N; Gillespie W; Vacek JC; Sen U; Tyagi SC; Lominadze D
J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor.
Lominadze D; Tyagi N; Sen U; Ovechkin A; Tyagi SC
Mol Cell Biochem; 2012 Dec; 371(1-2):89-96. PubMed ID: 22886392
[TBL] [Abstract][Full Text] [Related]
3. gamma-Aminbuturic acid A receptor mitigates homocysteine-induced endothelial cell permeability.
Tyagi N; Moshal KS; Tyagi SC; Lominadze D
Endothelium; 2007; 14(6):315-23. PubMed ID: 18080868
[TBL] [Abstract][Full Text] [Related]
4. GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemia.
Shastry S; Moning L; Tyagi N; Steed M; Tyagi SC
J Cell Physiol; 2005 Dec; 205(3):422-7. PubMed ID: 15895389
[TBL] [Abstract][Full Text] [Related]
5. GABA receptors ameliorate Hcy-mediated integrin shedding and constrictive collagen remodeling in microvascular endothelial cells.
Shastry S; Tyagi N; Moshal KS; Lominadze D; Hayden MR; Tyagi SC
Cell Biochem Biophys; 2006; 45(2):157-65. PubMed ID: 16757816
[TBL] [Abstract][Full Text] [Related]
6. GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice.
Kumar M; Tyagi N; Moshal KS; Sen U; Pushpakumar SB; Vacek T; Lominadze D; Tyagi SC
Brain Res; 2008 Jul; 1221():147-53. PubMed ID: 18547546
[TBL] [Abstract][Full Text] [Related]
7. Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice.
Steed MM; Tyagi N; Sen U; Schuschke DA; Joshua IG; Tyagi SC
Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L301-11. PubMed ID: 20581102
[TBL] [Abstract][Full Text] [Related]
8. Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity.
Tyagi N; Moshal KS; Sen U; Lominadze D; Ovechkin AV; Tyagi SC
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):21-7. PubMed ID: 17543202
[TBL] [Abstract][Full Text] [Related]
9. Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway.
Moshal KS; Sen U; Tyagi N; Henderson B; Steed M; Ovechkin AV; Tyagi SC
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C883-91. PubMed ID: 16251475
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.
Kumar M; Tyagi N; Moshal KS; Sen U; Kundu S; Mishra PK; Givvimani S; Tyagi SC
Neurochem Int; 2008 Dec; 53(6-8):214-9. PubMed ID: 18725259
[TBL] [Abstract][Full Text] [Related]
11. Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling.
Sen U; Herrmann M; Herrmann W; Tyagi SC
Clin Chem Lab Med; 2007; 45(12):1771-6. PubMed ID: 17990952
[TBL] [Abstract][Full Text] [Related]
12. Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells.
Sen U; Tyagi N; Kumar M; Moshal KS; Rodriguez WE; Tyagi SC
Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1779-87. PubMed ID: 17855772
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
Bao XM; Wu CF; Lu GP
Acta Pharmacol Sin; 2010 Apr; 31(4):476-84. PubMed ID: 20305681
[TBL] [Abstract][Full Text] [Related]
14. Mesenteric vascular remodeling in hyperhomocysteinemia.
Munjal C; Givvimani S; Qipshidze N; Tyagi N; Falcone JC; Tyagi SC
Mol Cell Biochem; 2011 Feb; 348(1-2):99-108. PubMed ID: 21076854
[TBL] [Abstract][Full Text] [Related]
15. PPARδ activation inhibits homocysteine-induced p22(phox) expression in EA.hy926 cells through reactive oxygen species/p38MAPK pathway.
Xiao GF; Xu SH; Chao Y; Xie LD; Xu CS; Wang HJ
Eur J Pharmacol; 2014 Mar; 727():29-34. PubMed ID: 24486703
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells via inhibiting NADPH oxidase-related oxidative stress-triggered p38MAPK signaling.
Bao XM; Wu CF; Lu GP
Acta Pharmacol Sin; 2009 Oct; 30(10):1392-8. PubMed ID: 19767766
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.
Steed MM; Tyagi SC
Antioxid Redox Signal; 2011 Oct; 15(7):1927-43. PubMed ID: 21126196
[TBL] [Abstract][Full Text] [Related]
18. Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Mishra PK; Tyagi N; Sen U; Joshua IG; Tyagi SC
Cardiovasc Diabetol; 2010 Sep; 9():49. PubMed ID: 20828387
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC.
Moshal KS; Singh M; Sen U; Rosenberger DS; Henderson B; Tyagi N; Zhang H; Tyagi SC
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2825-35. PubMed ID: 16877562
[TBL] [Abstract][Full Text] [Related]
20. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
Jia F; Wu C; Chen Z; Lu G
Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
